Sam Lockhart

Experts / Sam Lockhart

Wellcome Trust Clinical PhD Fellow, Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge

Sam is trainee diabetes and endocrinology doctor and a Wellcome Trust Clinical PhD student at the Institute of Metabolic Science, University of Cambridge. His work uses human genetics and model systems to discover novel causes and risk factors for human disease. He completed his undergraduate medical training at Queen’s University Belfast followed by a visting studentship in Joslin Diabetes Centre, Harvard Medical School before returning to the UK to begin his clinical academic training in Belfast as an Academic Foundation Doctor and then in Cambridge as an NIHR Academic Clinical Fellow in Diabetes and Endocrinology.

We think we have found a cause of pregnancy sickness, and it may lead to a treatment

Sickness in pregnancy, or hyperemesis gravidarum, is common and is thought to affect seven out of ten women at some time in their pregnancy. But, until recently, very little has been known about why it happens.

We think we have found a cause of pregnancy sickness, and it may lead to a treatment

Sickness in pregnancy, or hyperemesis gravidarum, is common and is thought to affect seven out of ten women at some time in their pregnancy. But, until recently, very little has been known about why it happens.

By Sam Lockhart, Prof Stephen O'Rahilly

Clinical Articles

Obstetrics and gynaecology

Sam Lockhart

Wellcome Trust Clinical PhD Fellow, Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge

More from this expert

We think we have found a cause of pregnancy sickness, and it may lead to a treatment

Sickness in pregnancy, or hyperemesis gravidarum, is common and is thought to affect seven out of ten women at some time in their pregnancy. But, until recently, very little has been known about why it happens.

We think we have found a cause of pregnancy sickness, and it may lead to a treatment

Sickness in pregnancy, or hyperemesis gravidarum, is common and is thought to affect seven out of ten women at some time in their pregnancy. But, until recently, very little has been known about why it happens.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Sam Lockhart

Wellcome Trust Clinical PhD Fellow, Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge

More from this expert

We think we have found a cause of pregnancy sickness, and it may lead to a treatment

Sickness in pregnancy, or hyperemesis gravidarum, is common and is thought to affect seven out of ten women at some time in their pregnancy. But, until recently, very little has been known about why it happens.

We think we have found a cause of pregnancy sickness, and it may lead to a treatment

Sickness in pregnancy, or hyperemesis gravidarum, is common and is thought to affect seven out of ten women at some time in their pregnancy. But, until recently, very little has been known about why it happens.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.